BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 31696802)

  • 1. Early Biomarkers for Severe Drug Hypersensitivity Reactions.
    Ariza A; Torres MJ; Moreno-Aguilar C; Fernández-Santamaría R; Fernández TD
    Curr Pharm Des; 2019; 25(36):3829-3839. PubMed ID: 31696802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug Hypersensitivity Reactions.
    Wilkerson RG
    Immunol Allergy Clin North Am; 2023 Aug; 43(3):473-489. PubMed ID: 37394254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allergy to betalactam antibiotics in children: results of a 20-year study based on clinical history, skin and challenge tests.
    Ponvert C; Perrin Y; Bados-Albiero A; Le Bourgeois M; Karila C; Delacourt C; Scheinmann P; De Blic J
    Pediatr Allergy Immunol; 2011 Jun; 22(4):411-8. PubMed ID: 21535179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Severe delayed drug hypersensitivity reactions].
    Maniu CM; Buss G; Feldmeyer L; Spertini F; Ribi C
    Rev Med Suisse; 2013 Apr; 9(382):803-4, 806-11. PubMed ID: 23667969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Phenotypes of Severe Cutaneous Drug Hypersensitivity Reactions.
    Guvenir H; Arikoglu T; Vezir E; Misirlioglu ED
    Curr Pharm Des; 2019; 25(36):3840-3854. PubMed ID: 31696807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin Allergy to Azole Antifungal Agents for Systemic Use: A Review of the Literature.
    Calogiuri G; Garvey LH; Nettis E; Romita P; Di Leo E; Caruso R; Butani L; Foti C
    Recent Pat Inflamm Allergy Drug Discov; 2019; 13(2):144-157. PubMed ID: 31538908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic allergies in children and adults: from clinical symptoms to skin testing diagnosis.
    Romano A; Caubet JC
    J Allergy Clin Immunol Pract; 2014; 2(1):3-12. PubMed ID: 24565763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe delayed skin reactions related to drugs in the paediatric age group: A review of the subject by way of three cases (Stevens-Johnson syndrome, toxic epidermal necrolysis and DRESS).
    Belver MT; Michavila A; Bobolea I; Feito M; Bellón T; Quirce S
    Allergol Immunopathol (Madr); 2016; 44(1):83-95. PubMed ID: 26089185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe Drug Hypersensitivity Reactions: Clinical Pattern, Diagnosis, Etiology and Therapeutic Options.
    Paulmann M; Mockenhaupt M
    Curr Pharm Des; 2016; 22(45):6852-6861. PubMed ID: 27779083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cutaneous Adverse Drug Reaction Caused by Antiepileptic Drug].
    Deguchi T; Abe R
    Brain Nerve; 2019 Apr; 71(4):401-406. PubMed ID: 30988229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic Tools and Biomarkers for Severe Drug Eruptions.
    Yoshioka M; Sawada Y; Nakamura M
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of in vivo and in vitro Tests in the Diagnosis of Severe Cutaneous Adverse Reactions (SCAR) to Drug.
    Bergmann MM; Caubet JC
    Curr Pharm Des; 2019; 25(36):3872-3880. PubMed ID: 31696801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug allergy].
    Sueki H
    Nihon Rinsho; 2009 Nov; 67(11):2139-43. PubMed ID: 19899530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokines/Chemokines: Novel Biomarkers Associated with Severe Cutaneous Adverse Reactions.
    Zhang X; Lu WS; Qin XM
    J Interferon Cytokine Res; 2020 Apr; 40(4):172-181. PubMed ID: 32195616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variants associated with T cell-mediated cutaneous adverse drug reactions: A PRISMA-compliant systematic review-An EAACI position paper.
    Oussalah A; Yip V; Mayorga C; Blanca M; Barbaud A; Nakonechna A; Cernadas J; Gotua M; Brockow K; Caubet JC; Bircher A; Atanaskovic-Markovic M; Demoly P; Kase-Tanno L; Terreehorst I; Laguna JJ; Romano A; Guéant JL; Pirmohamed M;
    Allergy; 2020 May; 75(5):1069-1098. PubMed ID: 31899808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulfonamide Hypersensitivity.
    Chow TG; Khan DA
    Clin Rev Allergy Immunol; 2022 Jun; 62(3):400-412. PubMed ID: 34212341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypersensitivity reactions to proton-pump inhibitors: Clinical presentation, diagnosis, and management.
    Kepil Özdemir S; Bavbek S
    Allergy Asthma Proc; 2020 Mar; 41(2):e37-e44. PubMed ID: 32122452
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevention of Drug Hypersensitivity Reactions: Prescreening and Premedication.
    Thong BY; Vultaggio A; Rerkpattanapipat T; Schrijvers R
    J Allergy Clin Immunol Pract; 2021 Aug; 9(8):2958-2966. PubMed ID: 34366094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basal serum tryptase is not a risk factor for immediate-type drug hypersensitivity during childhood.
    Cavkaytar O; Karaatmaca B; Arik Yilmaz E; Sahiner UM; Sackesen C; Sekerel BE; Soyer O
    Pediatr Allergy Immunol; 2016 Nov; 27(7):736-742. PubMed ID: 27288661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocyte transformation test and cytokine detection assays: Determination of read out parameters for delayed-type drug hypersensitivity reactions.
    Srinoulprasert Y
    J Immunol Methods; 2021 Sep; 496():113098. PubMed ID: 34216607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.